Intuitive Surgical (ISRG) shares sink to 52-week low of $427.79 amid institutional selling and FDA safety concerns, despite strong quarterly performance.

Many investors understandably have doubts about the company right now.

Intuitive Surgical's success hints that this competitor could have more growth potential than investors think.

Intuitive Surgical, Inc. (NASDAQ:ISRG) was among the stocks Jim Cramer highlighted, as he discussed the massive AI ...

Shares of Intuitive Surgical (NASDAQ: ISRG) jumped on Wednesday after the robotic-assisted surgery pioneer reported its ...

Surgical robots improve patient outcomes, making the technology highly attractive to both practitioners and patients. That is ...

FDA issues a safety communication on Intuitive Surgical's curved tip staplers after reports of serious injuries. Regulators flag potential safety, reputational, and operational risks tied to the ...

Robotic surgery has transformed the healthcare sector, improving patient treatment and outcomes. Intuitive Surgical (NASDAQ: ISRG) builds and sells the da Vinci, a robotic system used for various ...

These longtime market beaters may not have peaked yet.

Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 23% year on year to $2.77 billion. Its non-GAAP profit ...

Intuitive Surgical Inc (NASDAQ:ISRG) shares are trading higher Wednesday after the company reported preliminary financial results for the fourth quarter. What Happened: Intuitive Surgical said it ...

Intuitive Surgical (NASDAQ: ISRG) has rewarded long-term investors by climbing nearly 200% over the past five years. This is thanks to the company's leadership in a hot growth area: robotic surgery.